A Clinical Trial of PEGIFNα1b in Chinese Healthy Adults

Summary

This is a Phase I，randomized, double-blind, placebo controlled,dose escalated,single administrated clinical trial in Chinese healthy adult's volunteers. In the trial, it is planned to enroll 50 subjects, randomized to 5 dosage groups to receive the test drug and the placebo control.

Timeline

Start

2020-07-07

Primary completion

2020-10-22

Completion

2020-10-22

Drugs

Indications